Bayer gets nod for Kerendia to treat type 2 diabetes, CKD in Japan Ruchika Sharma1 April 2022 9:00 AM ISTBerlin: Bayer has recently announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted marketing authorization for...
Invasive Cardiac Management Accelerate Initiation of Dialysis in CKD patients MD Bureau30 March 2022 9:00 AM ISTIndividuals with end- stage kidney disease have poorer quality of life than the general population. Cardiovascular disease is the leading cause of...
Is high LDL-C good for CKD but bad for CAD? Study proposes optimal range Medha Baranwal21 March 2022 11:30 AM ISTChina: Findings from a recent study suggest that lower LDL-C is causally associated with a lower risk of atherosclerotic cardiovascular disease...
Off-clamp robot-assisted partial nephrectomy not superior to on-clamp technique: Study Medical Dialogues Editorial Team21 March 2022 9:00 AM ISTSt. Louis, MO: When compared to on-clamp partial nephrectomy, off-clamp robot-assisted partial nephrectomy had similar perioperative results. There...
Bayer applies in EU for extension of Indication to Finerenone MD Bureau20 March 2022 1:00 PM ISTThe submission is based on positive data from the FIGARO-DKD study, which demonstrated that finerenone significantly reduced the risk of...
CKD patients who forego dialysis may have long survival with sustained QOL: JAMA Medha Baranwal16 March 2022 11:00 AM ISTUSA: A recent review in JAMA Network Open has described long-term outcomes of patients with advanced chronic kidney disease (CKD) who do not pursue...
GLP 1 Receptor Agonists to have better outcomes Than DPP4 Inhibitors Dr. Nandita Mohan14 March 2022 5:00 PM ISTA recent study suggests that the use of GLP-1 receptor agonists was associated with better outcomes compared with the use of DPP-4 inhibitors among...
Management of CKD associated pruritus- Current treatment options and future approaches Medha Baranwal14 March 2022 9:00 AM ISTUSA: A recent study, published in the Clinical Kidney Journal, reports new guidelines for the clinical management of patients with chronic kidney...
KIMS gets green light for kidney transplant Adity Saha13 March 2022 11:30 AM ISTHubballi: The state government of Karnataka has given the green light to KIMS(Karnataka Institute of Medical Sciences) to perform the kidney...
GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Dr Kartikeya Kohli10 March 2022 10:30 AM ISTChronic kidney disease (CKD) and end-stage kidney disease (ESKD) are contributors to the health burden and are associated with increased mortality and...
ISN and AstraZeneca announce multi-year partnership for KCD MD Bureau9 March 2022 2:35 PM ISTChronic Kidney Disease (CKD) today has become a major cause of global mortality and morbidity.
Zydus to launch Desidustat breakthrough treatment for Anemia in CKD patients under brand name Oxemia MD Bureau7 March 2022 12:04 PM ISTOxemia is an oral, small molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor.
